| BIOMARIN PHAR. DL-,001 | 67,07 / -0,43% |
| 日付/時刻 | 15.01. / 08:07 |
| 変化 / 変化(%) | -0,29 / -0,43% |
| Bid | - |
| Ask | - |
| 始値 | 67,07 |
| 直前終値 | 67,36 |
| 高値 | 67,07 |
| 安値 | 67,07 |
| 出来高 [EUR] | 0,00 |
| 出来高 [Units] | 0 |
| Price fixings | 1 |
| ISIN | US09061G1013 |
| シンボル | BM8 |
| 取引所 | München |
| 種類 | 株式 |
すべての取引所
| 取引所 | 直近 | 出来高 | |
|---|---|---|---|
| Lang & Schwa.. | 67,95 |  |
|
| NASDAQ | 82,9700 |  |
1.306.558 |
| Cboe US | 82,85 | |
89.343 |
| IEX | 82,89 | |
62.135 |
| TradeGate | 68,200 | |
988 |
| Vienna Globa.. | 68,08 | |
849 |
| gettex | 69,110 | |
70 |
| Frankfurt | 67,7500 | |
64 |
| Xetra | 68,08 | |
0 |
| Berlin | 66,75 | |
0 |
| München | 67,07 | |
0 |
| Düsseldorf | 68,45 | |
0 |
| Stuttgart | 68,800 | |
0 |
| Mexico | 1.599,31 | |
4.200 |
| London Inter.. | 81,84 | 295 |
ニュース
- BioMarin sinks 32% as FDA delays its hemophilia treatment
19.08.2020 / 16:23 - TeleTrader - Nasdaq turns red as pharma stocks fall
28.04.2020 / 16:48 - TeleTrader - BioMarin Enrolls First Participant in Phase 3 Trial of Vosoritide for Treatment of Children with Achondroplasia
12.12.2016 / 14:29 - GlobeNewswire - NICE Recommends BioMarin's Vimizim® (elosulfase alfa) for the Treatment of Morquio A Syndrome in England
23.11.2015 / 16:59 - GlobeNewswire